GMP Inspectors Will Scrutinize Adverse Event Reporting Compliance

27 Feb 2013

• By Elizabeth Crawford

Regular under-reporting of serious adverse event reports has spurred FDA to have its good manufacturing practice inspectors review dietary supplement firms’ AERs and reporting practices, FDA’s Fabricant says. Key compliance issues can tip off the agency that a company may be falling short on reporting.

With under-reporting of serious adverse events rampant, FDA’s good manufacturing practices inspections will look closer at dietary supplement firms’ compliance with AER regulations, said Division of Dietary Supplement Programs Director Dan Fabricant.

The agency, in turn, likely will increase enforcement actions against AER rule violations.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

US FDA’s Rising First-Cycle Complete Response Rate Draws Congress’ Attention

11 Jun 2025

• By Sue Sutter

The House Appropriations Committee wants an analysis of how issues that led to CRLs could have been resolved within the first review cycle and seeks an agency crackdown on counterfeit GLP-1 agonists.

‘Clean Sweep’ Of US CDC Vaccine Committee Puts Kennedy In Driver’s Seat

10 Jun 2025

• By Bridget Silverman

With a 25-27 June meeting looming, HHS Secretary Robert F. Kennedy Jr. can fill all 17 spots on the CDC's Advisory Committee on Immunization Practices with people he says will "exercise independent judgment."